SYRA HEALTH CORP - CLASS A (SYRA) Stock Income Statement
NASDAQ:SYRA - Nasdaq - US87168W2035 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 7.98M | 5.52M | 5.62M | 1.41M | 0.00 | |||
| Cost Of Goods | 6.33M | 4.10M | 4.56M | 980.00K | 0.00 | |||
| Gross Profit | 1.65M | 1.41M | 1.06M | 430.00K | 0.00 | |||
| Operating Expenses | 5.42M | 4.30M | 3.15M | 430.00K | 0.00 | |||
| Research and Development | 585.10K | 240.10K | N/A | N/A | N/A | |||
| Selling, General, and Administrative Expenses | 4.77M | 4.01M | 3.14M | 430.00K | 0.00 | |||
| Operating Income | -3.76M | -2.89M | -2.09M | 0.00 | 0.00 | |||
| Interest Income/Expense | 5.60K | -50.80K | -30.00K | 0.00 | N/A | |||
| Income Before Taxes | -3.76M | -2.94M | -2.12M | 0.00 | 0.00 | |||
| Net Income | -3.76M | -2.94M | -2.12M | 0.00 | 0.00 | |||
| EBITDA | -3.70M | -2.84M | -2.08M | N/A | N/A | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.50 | -0.60 | -0.35 | 0.00 | 0.00 | |||
| Statistics | ||||||||
| Gross Profit Margin | 20.71% | 25.60% | 18.86% | 30.50% | N/A | |||
| Profit Margin | -47.10% | -53.28% | -37.72% | N/A | N/A | |||
| Operating Profit Margin | -47.17% | -52.36% | -37.19% | N/A | N/A | |||
All data in USD